SCHEMBL26415934

SCHEMBL26415934

Cc1cc(C)c(OCc2ccccc2)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.53
MAPT P10636 1/20 0.53
MAPK1 P28482 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
STAT3 P40763 1/20 0.50
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
BRD4 O60885 3/20 0.49
FFAR4 Q5NUL3 1/20 0.49
LMNA P02545 2/20 0.46
LIPE Q05469 1/20 0.45
GCK P35557 2/20 0.44
LTA4H P09960 1/20 0.44
MAPK14 Q16539 1/20 0.44
ATP4A P20648 1/20 0.43
ATP4B P51164 1/20 0.43
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43
GSK3B P49841 1/20 0.43
CDK5 Q00535 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19598011 0.88 STAT3 (0.55) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL31517975 0.83 MAPK1 (0.50) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL26416014 0.83 MAPT (0.50) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL26445880 0.83 MAPT (0.50) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL23663288 0.83 MAPT (0.54) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL23663332 0.83 MAPT (0.50) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL10374510 0.83 PDGFRB (0.54) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL24583106 0.83 MAPT (0.50) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL25081934 0.81 MAPT (0.64) L3MBTL1MAPTMAPK1TDP1STAT3
SCHEMBL16455676 0.81 MAPT (0.47) L3MBTL1MAPTMAPK1TDP1STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780825-B2 Thyroid hormone receptor agonists and use thereof ECCOGENE (SHANGHAI) CO., LTD. (CN) 2023-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780825-B2 Thyroid hormone receptor agonists and use thereof TSHR, THRA, THRB L3MBTL1 4551/4885MAPT 112/4885MAPK1 1462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.